Business Description
Vaxcyte Inc
NAICS : 541713
SIC : 2834
ISIN : US92243G1085
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 54.21 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.06 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -10.7 | |||||
3-Year EPS without NRI Growth Rate | -4.4 | |||||
3-Year FCF Growth Rate | -32.4 | |||||
3-Year Book Growth Rate | 24.3 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.73 | |||||
9-Day RSI | 55.72 | |||||
14-Day RSI | 52.69 | |||||
6-1 Month Momentum % | 32.29 | |||||
12-1 Month Momentum % | 21.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 17.42 | |||||
Quick Ratio | 17.42 | |||||
Cash Ratio | 17.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -23.1 | |||||
Shareholder Yield % | -19.93 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -31.18 | |||||
ROA % | -29.1 | |||||
ROIC % | -143.41 | |||||
ROC (Joel Greenblatt) % | -570.65 | |||||
ROCE % | -32.24 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.57 | |||||
Price-to-Tangible-Book | 3.57 | |||||
EV-to-EBIT | -12.35 | |||||
EV-to-EBITDA | -12.65 | |||||
EV-to-FCF | -11.67 | |||||
Price-to-Net-Current-Asset-Value | 5.03 | |||||
Price-to-Net-Cash | 5.14 | |||||
Earnings Yield (Greenblatt) % | -8.1 | |||||
FCF Yield % | -6.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Vaxcyte Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -4.531 | ||
Beta | 1.37 | ||
Volatility % | 39.22 | ||
14-Day RSI | 52.69 | ||
14-Day ATR (€) | 1.090135 | ||
20-Day SMA (€) | 58.575 | ||
12-1 Month Momentum % | 21.9 | ||
52-Week Range (€) | 41.2 - 75.5 | ||
Shares Outstanding (Mil) | 108.8 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vaxcyte Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vaxcyte Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Vaxcyte Inc Frequently Asked Questions
What is Vaxcyte Inc(FRA:5VA)'s stock price today?
When is next earnings date of Vaxcyte Inc(FRA:5VA)?
Does Vaxcyte Inc(FRA:5VA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |